Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mtdsus mtdsus Nov 20, 2012 9:51 AM Flag

    FORBES ARTICLE makes strong case for "CO-MARKETING AGREEMENT"

    Forbes writer Matthew--is a very incompetent Journalist.
    1) He says--Jelis was only one study that proved its effectiveness for reducing Cardiac events.
    2) He never bothered to read the study--18,000 people studied for 6 years in Japan.
    3) He mingles product like Vascepa and Epadel with studies for Lovaza and Fish Oils that contain over 50% of DHA. EPA helps-DHA hurts Lipid profile. Lovaza may lower triglycerides but by raising LDL--most important Lipid profile--it causes problems with Heart.
    He wrote an article in 2008--"One Supplement that works"-he was refering to FISH OIL and LOVAZA-based on FAULTY STUDIES.

 
AMRN
1.32+0.04(+3.13%)11:53 AMEST